Pharmaceuticals, Biotechnology and Life Sciences
Full-Year Revenue Increased 14.5% to $34 Million Fourth Quarter Revenue Up 20.0% to $8 Million LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc.…
MENLO PARK, Calif.–(BUSINESS WIRE)–Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering…
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…
Company Advancing ALPN-101 into a Phase 1/2 Acute Graft versus Host Disease Study (BALANCE) Phase 1 Study (NEON-1) of Lead…
– Completion of patient enrollment in Phase 3 clinical study of omidubicel expected by year-end; Topline data anticipated in first…
AmeriHealth Caritas Offers Ideas for Reducing Childhood Immunization Disparities PHILADELPHIA–(BUSINESS WIRE)–#AmeriHealthCaritas–According to research by the Centers for Disease Control and…
Three multimedia platforms spanning oncology, cannabis technology and practice management receive prestigious honors for editorial content and design CRANBURY, N.J.–(BUSINESS…
DUBLIN–(BUSINESS WIRE)–The “United States Digital Pathology Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024” report has been…
In-vivo Models Showed that Only AsiDNA™ Could Delay Resistance to Carboplatin without Increasing its Toxicity PARIS–(BUSINESS WIRE)–Regulatory News: Onxeo S.A.…